CSPC ZhongQi Pharmaceutical Technology

NCT07241936

Phase 1/2, Recruiting, 2025, 444 people, 21 Nov 2025, clinicaltrials.gov

NCT07165886

Phase 2/3, Recruiting, 2025, 298 people, 10 Sept 2025, clinicaltrials.gov

NCT06941142

Phase 1, Not yet recruiting, 2025, 382 people, 23 Apr 2025, clinicaltrials.gov

NCT06161844

Phase 3, Completed, 2024, 506 people, 8 Dec 2023, clinicaltrials.gov

NCT05715840

Phase 3, Status unknown, 2023, 368 people, 8 Feb 2023, clinicaltrials.gov

NCT05097248

Collaborator, Phase 2, Status unknown, 2021, 52 people, 28 Oct 2021, clinicaltrials.gov

NCT05045313

Phase 1, Completed, 2021, 28 people, 16 Sept 2021, clinicaltrials.gov

NCT04859452

Phase 1, Completed, 2021, 56 people, 26 Apr 2021, clinicaltrials.gov

NCT04689100

Collaborator, Phase 1, Status unknown, 2017, 259 people, 30 Dec 2020, clinicaltrials.gov

NCT04218734

Phase 3, Completed, 2020, 214 people, 6 Jan 2020, clinicaltrials.gov

NCT04161430

Phase 3, Completed, 2020, 766 people, 13 Nov 2019, clinicaltrials.gov

NCT03830684

Phase 2, Status unknown, 2019, 180 people, 5 Feb 2019, clinicaltrials.gov

NCT03262948

Phase 3, Status unknown, 2017, 388 people, 28 Aug 2017, clinicaltrials.gov

NCT02595242

Phase 1, Withdrawn, 2015, 0 people, 3 Nov 2015, clinicaltrials.gov